In vivo treatment of human acute promyelocytic leukemia with a histone deacetylase inhibitor, FR901228.

被引：0
|
作者：
Kosugi, H
Towatari, M
Ito, M
Ito, M
Saito, H
Naoe, T
机构：
[1] Nagoya Univ, Sch Med, Dept Internal Med 1, Nagoya, Aichi 466, Japan
[2] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan
[3] Nagoya Univ, Sch Med, Dept Infect Dis, Nagoya, Aichi 466, Japan
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2261
引用
收藏
页码：505A / 505A
页数：1
相关论文
共 50 条
  • [1] Phase I trial of the histone deacetylase inhibitor. Depsipeptide (FR901228) in acute myeloid leukemia (AML).
    Marcucci, G
    Bruner, RJ
    Binkley, PF
    Xiao, J
    Chan, KK
    Parthun, M
    Davis, M
    Fischer, B
    Shank, R
    Moran, M
    Byrd, JC
    Grever, M
    BLOOD, 2002, 100 (11) : 86A - 86A
  • [2] FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
    Nakajima, H
    Kim, YB
    Terano, H
    Yoshida, M
    Horinouchi, S
    EXPERIMENTAL CELL RESEARCH, 1998, 241 (01) : 126 - 133
  • [3] Histone deacetylase inhibitor FR901228 enhances adenovirus infection of hematopoietic cells
    Kitazono, M
    Rao, VK
    Robey, R
    Aikou, T
    Bates, S
    Fojo, T
    Goldsmith, ME
    BLOOD, 2002, 99 (06) : 2248 - 2251
  • [4] Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
    Warrell, RP
    He, LZ
    Richon, V
    Calleja, E
    Pandolfi, PP
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (21): : 1621 - 1625
  • [5] Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma
    Khan, SB
    Maududi, T
    Barton, K
    Ayers, J
    Alkan, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) : 156 - 161
  • [6] Acute promyelocytic leukemia, histone deacetylase and response to retinoids
    Jeanteur, P
    BULLETIN DU CANCER, 1998, 85 (04) : 301 - 303
  • [7] Re: Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
    Samid, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (05) : 475 - 476
  • [8] Targeted transcription therapy of acute promyelocytic leukemia using an inhibitor of histone deacetylase.
    Warrell, RP
    He, LZ
    Richon, V
    Calleja, E
    Pandolfi, PP
    BLOOD, 1998, 92 (10) : 219B - 219B
  • [9] Phase I trial of the histone deacetylase inhibitor depsipeptide (FR901228) in fludarabine refractory chronic lymphocytic leukemia.
    Bruner, RJ
    Marcucci, G
    Binkley, P
    Xiao, J
    Chan, K
    Parthun, M
    Davis, M
    Fischer, B
    Shank, R
    Moran, M
    Grever, M
    Byrd, JC
    BLOOD, 2002, 100 (11) : 385A - 385A
  • [10] In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice
    Kosugi, H
    Ito, M
    Yamamoto, Y
    Towatari, M
    Ito, M
    Ueda, R
    Saito, H
    Naoe, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (05): : 529 - 536
12345